Oxidative and nitrosative stress in serum of patients with Parkinson’s disease
Authors:
- Hikmet Can ÇubukçuHÇHikmet Can Çubukçu
- Hikmet CanHCHikmet Can
- Hafize NalanHNHafize Nalan
- İlker DurakIDİlker Durak
- 16 July 2016
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 37 (11) , 1793-1798
Abstract
Parkinson’s disease (PD) is one of the common neurodegenerative disorders. Oxidative stress is considered as a contributing factor to the development of PD. The present study aims to investigate serum oxidative stress status in patients with PD. Oxidative stress was assessed by measuring serum nitric oxide levels, lipid hydroperoxide concentrations, and nitric oxide synthase activity. In addition, total serum antioxidant capacity (TAC) was evaluated using the serum 2,2-Diphenyl-1-picryl-hydrazyl (DPPH) free-radical scavenging method in 32 patient with Parkinson’s disease and 32 control subjects. Our results indicated that serum nitric oxide and lipid hydroperoxide levels were significantly lower in patients with PD than controls. Moreover, nitric oxide levels were found to be negatively correlated with Unified Parkinson’s Disease Rating Scale (UPDRS). However, no statistical difference was observed in total serum antioxidant capacities and nitric oxide synthase activities between patients and controls. The present study indicates that although antioxidant capacity was not changed, lipid hydroperoxide (LPO) level was found decreased. This might show pre-oxidative process in these patients. In addition, decreased nitric oxide (NO) level and negative correlation observed between NO level and disease rating scale implicated a role for NO in the disease process.Keywords
This publication has 42 references indexed in Scilit:
- Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson diseaseFree Radical Biology and Medicine, 2013
- Aberrant Protein S-Nitrosylation in Neurodegenerative DiseasesNeuron, 2013
- Assessment of Parkinson Disease ManifestationsCurrent Protocols in Neuroscience, 2009
- Oxidative and nitrosative stress in Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Serum Insulin-Like Growth Factor-1 and Nitric Oxide Levels in Parkinson's DiseaseMediators of Inflammation, 2009
- Oxidative stress in Parkinson’s diseaseIndian Journal of Clinical Biochemistry, 2009
- A review of Parkinson's diseaseBritish Medical Bulletin, 2008
- NITRITE AND MALONDIALDEHYDE CONTENT IN CEREBROSPINAL FLUID OF PATIENTS WITH PARKINSON’S DISEASEInternational Journal of Neuroscience, 2006
- Serum antioxidant capacity in neurological, psychiatric, renal diseases and cardiomyopathyJournal of Neural Transmission, 2002
- Determination of Lipid Hydroperoxides in Serum Iodometry and High Performance Liquid Chromatography ComparedClinical Chemistry and Laboratory Medicine (CCLM), 1992